Medication info
Gengboraprazole Tablet 10 mg (Rabeprazole Sodium)

Gengboraprazole Tablet 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Gengbo Pharmaceutical Co., Ltd.
Appearance
Yellowish round enteric-coated tablets
Packaging
28 tablets (14 tablets/alu-alu packaging × 2)
Approval status
Active

MFDS item code 201405854 · Approved 2014.12.11 · Insurance code 665001900

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including combination therapy for eradication), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, treatment with 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled with on-demand therapy using 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g together twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution, as hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Gengbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including combination therapy for eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome.
View approved original text

This medication is used to treat gastric ulcers, duodenal ulcers, and erosive or ulcerative gastroesophageal reflux disease. It is also effective for relief of symptoms due to gastroesophageal reflux disease and for long-term maintenance therapy. For patients with gastrointestinal ulcers due to Helicobacter pylori infection, it is used in combination with antibiotics. It also helps inhibit excessive gastric acid secretion in patients with Zollinger-Ellison syndrome. Overall, it is used for the treatment of various gastrointestinal conditions and symptom improvement.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, treatment with 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled with on-demand therapy using 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g together twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution, as hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This drug should not be used in patients with allergies or a history of hypersensitivity to certain ingredients. Caution is especially needed for those allergic to penicillin or macrolide antibiotics and those taking specific heart-related medications. It is safer for pregnant or breastfeeding women to avoid taking this medication. Patients with impaired liver function or elderly individuals may experience side effects more readily, so use should be carefully monitored. If allergy symptoms such as skin rashes or itching occur during use of this drug, dosing should be stopped immediately, and regular blood tests and liver function tests are recommended. Side effects may occur in various areas including liver function abnormalities, heart, gastrointestinal, nervous system, respiratory, musculoskeletal, and skin; therefore, attention to symptoms is necessary. Prolonged use may increase the risk of osteoporosis and fractures, and symptoms of magnesium deficiency may occasionally occur, necessitating blood tests if required. Additionally, inhibition of gastric acid secretion may slightly increase the risk of bacterial infections in the gastrointestinal tract, so consultation with healthcare providers is advised if diarrhea persists. Caution is required when driving or operating machinery, as drowsiness may occur. The potential for drug interactions exists, so consultation with healthcare professionals is crucial, especially when used in combination with antibiotics, antivirals, anticoagulants, etc. This medication should be swallowed whole without chewing or crushing, and stored out of reach of children. In cases of overdose, adequate treatment according to symptoms is necessary, as no specific antidote exists.

Side effects

Rash, hives, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, indigestion, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatoencephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, asthenia, neurosensitivity, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, increased blood circulation volume, upper and lower limb flaccidity, sensory loss, decreased grip strength, language confusion, staggering, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, nosebleeds, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonic muscle disorder, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane pemphigoid, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, increased urination, dysmenorrhea, painful urination, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal secretion, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, appetite loss, neck stiffness, phototoxic reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatoencephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus, nausea, bad breath, dry mouth, liver function abnormalities, chest tightness, allergic reactions, hypertriglyceridemia, hypercholesterolemia, palpitations, elevated intraocular pressure, urinary tract infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degrees Celsius and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Yellowish round enteric-coated tablets

Package unit

28 tablets (14 tablets/alu-alu packaging × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.